The Toxicity of Time During the COVID-19 Pandemic
“I always work hard to help my patients live as long as possible, but now I have the added goal of helping them live to see a post-pandemic world,” writes Dr. Suneel D. Kamath.
Related Articles
Colorectal Cancer Liver Metastasis
Tune in to learn about the current state of disease management and the potential of ctDNA testing to guide treatment decisions and monitor disease progression.
Colorectal Cancer Liver Metastasis
Tune in to learn about the current state of disease management and the potential of ctDNA testing to guide treatment decisions and monitor disease progression.
Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer
Scientific Reports – Plasma metabolomic differences in early-onset compared to average-onset colorectal cancer
Stomach cancer killed Toby Keith at 62. The disease can strike young and be hard to spot.
Stomach cancer used to be a leading killer in the United States, and continues to have easy-to-mistake symptoms. Here’s when to talk to a doctor.
Disparities in National Cancer Institute and Nonprofit Organization Funding Disproportionately Affect Cancers With Higher Incidence Among Black Patients and Higher Mortality Rates
PURPOSE National Cancer Institute (NCI) and nonprofit organization (NPO) funding is critical for research and advocacy but may not be equitable across cancers. METHODS This…
Disparities in National Cancer Institute and Nonprofit Organization Funding Disproportionately Affect Cancers With Higher Incidence Among Black Patients and Higher Mortality Rates
PURPOSE National Cancer Institute (NCI) and nonprofit organization (NPO) funding is critical for research and advocacy but may not be equitable across cancers. METHODS This…
Survival of Patients With Cancer With DPYD Variant Alleles and Dose-Individualized Fluoropyrimidine Therapy—A Matched-Pair Analysis
Outcome of DPYD variant allele carriers treated with dose-individualized fluoropyrimidine therapy.
Metabolomic Differences: Young Onset (yoCRC) vs. Average Onset (aoCRC) Colorectal Cancer
Listen as Dr. Kamath talks about the challenges associated with early detection, the evolving landscape of screening guidelines, potential contributing factors to the rise of…
Metabolomic Differences: Young Onset (yoCRC) vs. Average Onset (aoCRC) Colorectal Cancer
Listen as Dr. Kamath talks about the challenges associated with early detection, the evolving landscape of screening guidelines, potential contributing factors to the rise of…